Meatable, a food technology company, announced that it has reached an important milestone in its efforts to produce cultivated meat at scale. Meatable is now able to transform pluripotent stem cells (PSCs) into high quality fat and muscle tissue in a record four days, down from eight days. The breakthrough will enable the company to produce cultivated meat significantly faster and at lower costs than industry norms, and is therefore an important step towards the commercialization of Meatable’s technology and large-scale production of cultivated meat products more broadly.

The breakthrough, using Meatable’s core patented Opti-Ox technology, confronts the challenges faced by the cultivated meat industry to produce product fast and efficiently in order to scale to commercial levels. With its process enabling movement from “cell-to-sausage” in only four days, Meatable can produce high-quality cultivated meat at a significantly reduced cost. By reducing cell differentiation time in half, Meatable’s process now requires nearly half as many bioreactors at scale, cutting CAPEX costs and enabling a more efficient use of production space. By utilizing less labour, energy, infrastructure, ingredients and water, Meatable’s process has become more scalable and cost-efficient, as well as more sustainable for the world’s environment.